TY  - RPRT
TI  - BRAF V600 and ErbB inhibitors directly activate GCN2 in an off-target manner to limit cancer cell proliferation
AU  - Ill, C. R.
AU  - Marikar, N. C.
AU  - Nguyen, V.
AU  - Nangia, V.
AU  - Darnell, A. M.
AU  - Vander Heiden, M. G.
AU  - Reigan, P.
AU  - Spencer, S. L.
PY  - 2024
DO  - 10.1101/2024.12.19.629301
UR  - https://www.biorxiv.org/content/10.1101/2024.12.19.629301v1
ID  - 10.1101/2024.12.19.629301
ER  -